ASMB
Assembly Biosciences Inc
Halal Rating :
Last Price
$14.23
Last updated:
Market Cap
-
7D Change
-4.43%
1 Year Change
1573.72%
Company Overview
Industries
Exchange
Next Earnings Date
Assembly Biosciences Inc is a clinical-stage biotechnology company focused on developing innovative treatments for chronic hepatitis B virus (HBV) infection and other viral diseases. The company's primary focus is on creating novel therapeutic candidates that target the HBV lifecycle and core protein.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $6.84m | $17.8m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $8.53m | $20.74m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $5.79m | $16.51m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Assembly Biosciences Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.